Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation

Stock Information for Avalo Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avalo Therapeutics Inc.

Horizon Technology Finance to Announce First Quarter 2024 Financial Results
Horizon Technology Finance Provides First Quarter 2024 Portfolio Update
Horizon Technology Finance Announces Monthly Distributions for April, May and June 2024 Totaling $0.33 per Share and Special Distribution for April 2024 of $0.05 per Share
Horizon Technology Finance Announces Fourth Quarter and Full Year 2023 Financial Results
Horizon Technology Finance to Announce Fourth Quarter 2023 Financial Results
Horizon Technology Finance Provides Fourth Quarter 2023 Portfolio Update
Horizon Technology Finance Announces Monthly Distributions for January, February and March 2024 Totaling $0.33 per Share and Special Distribution for December 2023 of $0.05 per Share
Horizon Technology Finance Announces Third Quarter 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.